NCT05201521 is a clinical trial in Functional Movement Disorders, sponsored by Ruijin Hospital.

Who is sponsoring NCT05201521?

NCT05201521 is sponsored by Ruijin Hospital.

What condition does NCT05201521 study?

NCT05201521 studies Functional Movement Disorders.

Is NCT05201521 still recruiting?

NCT05201521 is currently status unknown. Last updated 21 January 2022.

Last reviewed 2022-01-21 · How we verify

NCT05201521

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chinese FMDs Registry

Status unknown Last updated 21 January 2022

What this trial tests

trial in Functional Movement Disorders in 100 participants. Status unknown.

Timeline

27 January 2022

Primary endpoint
31 August 2023

27 January 2024

Quick facts

Lead sponsor	Ruijin Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	27 January 2022
Primary completion	31 August 2023
Estimated completion	27 January 2024
Sites	1 location across China

Conditions studied

Functional Movement Disorders — all drugs for Functional Movement Disorders →

Sponsor

Ruijin Hospital

Who can join

Adults 18 to 80, any sex, with Functional Movement Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the Chinese Functional Movement Disorders Registry (FMDs-China) is to develop a database of patients with Functional Movement Disorders (FMDs) in China.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05201521 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 21 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05201521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing